A5017245441- Parkinson's Disease Mechanisms and Treatments
- Cerebral Palsy and Movement Disorders
- Dysphagia Assessment and Management
- Chronic Disease Management Strategies
- Balance, Gait, and Falls Prevention
- Substance Abuse Treatment and Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Acute Ischemic Stroke Management
- Neurological disorders and treatments
- Opioid Use Disorder Treatment
Radboud University Medical Center
2021-2024
Radboud University Nijmegen
2021-2024
Ghaem Hospital
2021
Mashhad University of Medical Sciences
2021
Abstract Introduction The PRIME-NL study prospectively evaluates a new integrated and personalized care model for people with parkinsonism, including Parkinson’s disease, in selected region (PRIME) the Netherlands. We address generalizability sources of selection confounding bias by examining baseline 1-year compliance data. Methods First, we assessed regional differences between PRIME usual (UC) using healthcare claims data almost all disease Netherlands (the source population). Second,...
ABSTRACT Background Specialized versus generic physiotherapy (PT) reduces Parkinson's disease (PD)–related complications. It is unclear (1) whether other specialized allied heath disciplines, including occupational therapy (OT) and speech language (S&LT), also reduce complications; (2) there a synergistic effect among multiple disciplines; (3) each health discipline prevents specific Objectives To longitudinally assessed the level of expertise (specialized vs. training) PT, OT, S&LT...
Little is known regarding long-term stroke outcomes in patients with substance use disorder (SUD). Based on anecdotal data, some individuals illicit drugs, particularly opioids, an attempt to reduce mortality, disability, or recurrence. This study aimed assess the effect of SUD outcomes.Patients were recruited from Mashhad Stroke Incidence Study, a population-based Iran. For period 1 year, all first-ever (FES) and then followed up for next 5 years. Disability functional dependency defined...
Abstract Background The ideal timing for initiating levodopa in newly diagnosed people with Parkinson's disease (PD) is uncertain due to limited data on the long‐term effects of levodopa. Objective aim was investigate whether early initiation postpones mortality (primary outcome), requirement device‐aided therapies, and incidence PD‐related complications, such as fall‐induced injuries. Methods Using nationwide claims from Dutch hospitals (2012–2020), we grouped PD individuals “early...